We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Control DNA Panels for PCR Studies

By Biotechdaily staff writers
Posted on 29 Oct 2004
A panel of control DNA samples for polymerase chain reaction (PCR) studies has been established to aid researchers working on gene regulation.

Sigma, a division of Sigma-Aldrich Corporation (St. More...
Louis, MO, USA), and the European Collection of Cell Cultures (ECACC) (Porton Down, UK) have established the human random control (HRC) DNA collection obtained from 480 UK Caucasian blood donors.

The DNA samples are maintained in lymphoblastoid cell lines derived by Epstein Barr Virus (EBV) that can be continuously propagated in culture. All samples are completely defined and standardized so that they may be used as reference standards for research or quality control.

The purified DNA is available in five different panels. Each panel contains 10 micrograms of DNA at a concentration of 200 nanograms/microliter and represents 96 individuals. For convenience, three of the panels are available in 96-well format for use in PCR without the need for aliquoting or dilution at a concentration of 8 nanograms/microliter.

"The ECACC HRC control panels are an excellent complement to Sigma's Quantitative PCR product offering,” said Keith Jolliff, global marketing manager of molecular biology at Sigma-Aldrich. "The DNA panels are unique products that offer researchers convenience and quality control for gene regulation and quantification studies.”



Related Links:
Sigma-Aldrich Corporation
European Collection of Cell Cultures

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.